Drugs / 111-Indium-CMD-193
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00293215 | Feb 2006 → May 2007 | neoplasm | Ludwig Institute for Cancer Research | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 111-Indium-CMD-193 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00293215 ↗ |
| Modality | Diagnostic / imaging agent | “The first cycle was trace labeled with (111)In for biodistribution assessment using gamma camera imaging.” PMID 19825951 ↗ Oct 2009 |
| Route | Intravenous | “111-In-CMD-193 (3-7 mCi) was administered as an IV infusion over 60 (± 5) minutes.” NCT00293215 ↗ |